Immune hemolytic anemia associated with probenecid.
Upon hospital admission a patient was found to have severe anemia and a strongly positive direct antiglobulin test (DAT). The patient was taking probenecid periodically for gout. An antibody was detected in the patient's serum that only reacted with red blood cells (RBCs) when probenecid was added. Eluates from the patient's RBCs, with and without the presence of drug, were nonreactive. Upon the discontinuation of probenecid, the patient's hemoglobin level improved steadily. We believe this to be the first reported case of immune hemolytic anemia associated with probenecid.
D000017:ABO Blood-Group System; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D001788:Blood Grouping and Crossmatching; D006801:Humans; D008297:Male; D008875:Middle Aged; D011339:Probenecid / Q000009:adverse effects*
D000017:ABO Blood-Group System; D011339:Probenecid